S2 Episode 2: Recognizing the Signs: Heart Failure and Type 2 Diabetes

S2 Episode 2: Recognizing the Signs: Heart Failure and Type 2 Diabetes

Join Dr Carol Wysham and Dr Javed Butler as they discuss the stealth complication of heart failure in patients with type 2 diabetes, including subtle signs and symptoms of heart failure and the importance of early detection and treatment.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982415). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes https://www.nejm.org/doi/full/10.1056/nejmoa1504720

Framingham Heart Study https://www.framinghamheartstudy.org/

Heart Failure https://emedicine.medscape.com/article/163062-overview

Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association https://diabetesjournals.org/care/article/45/7/1670/147048/Heart-Failure-An-Underappreciated-Complication-of

Brain-Type Natriuretic Peptide (BNP) https://emedicine.medscape.com/article/2087425-overview

The Effect of Spironolactone on Morbidity and Mortality in Patients With Severe Heart Failure https://www.nejm.org/doi/full/10.1056/NEJM199909023411001

Eplerenone in Patients With Systolic Heart Failure and Mild Symptoms https://www.nejm.org/doi/full/10.1056/nejmoa1009492

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063

Episoder(18)

S3 Episode 6: Continuous Glucose Monitoring in Clinical Type 2 Diabetes Practice: Benefits, Accessibility, and Patient Resistance

S3 Episode 6: Continuous Glucose Monitoring in Clinical Type 2 Diabetes Practice: Benefits, Accessibility, and Patient Resistance

Drs Carol H. Wysham and Grazia Aleppo discuss how and when to use CGM in clinical type 2 diabetes practice, navigating patient resistance, and benefits in gestational diabetes. Relevant disclosures ca...

25 Jun 202521min

S3 Episode 5: Choosing Which Agents to Use in the Management of CKD in Type 2 Diabetes Patients: SGLT2 Inhibitors vs GLP-1s

S3 Episode 5: Choosing Which Agents to Use in the Management of CKD in Type 2 Diabetes Patients: SGLT2 Inhibitors vs GLP-1s

Drs Carol H. Wysham and Liana K. Billings discuss how to incorporate SGLT2 inhibitors and GLP-1 receptor agonists into the management of patients with type 2 diabetes and chronic kidney disease. Relev...

22 Mai 202522min

S3 Episode 4: Heart Failure, Incretin Therapies, and Type 2 Diabetes

S3 Episode 4: Heart Failure, Incretin Therapies, and Type 2 Diabetes

Drs Carol H. Wysham and Christopher M. Kramer discuss heart failure and type 2 diabetes, and the role of incretin therapies in the management of HFpEF. Relevant disclosures can be found with the episo...

24 Apr 202521min

S3 Episode 3: 2025 ADA Updates: Comorbidities, Dental Care, Weight Loss, Sexual Dysfunction, and CGM Use for Type 2 Diabetes

S3 Episode 3: 2025 ADA Updates: Comorbidities, Dental Care, Weight Loss, Sexual Dysfunction, and CGM Use for Type 2 Diabetes

Drs Carol H. Wysham and Rozalina G. McCoy discuss the 2025 updates of the American Diabetes Association, including comorbidities, dental care, sexual dysfunction, and CGM use. Relevant disclosures can...

25 Mar 202524min

S3 Episode 2: Treating Type 2 Diabetes in an Aging Population: Geriatric Syndromes, Comorbidities, and Treatment De-escalation

S3 Episode 2: Treating Type 2 Diabetes in an Aging Population: Geriatric Syndromes, Comorbidities, and Treatment De-escalation

Drs Carol H. Wysham and Medha Munshi discuss type 2 diabetes in older adults, understanding geriatric syndromes and how they impact care, and when to de-escalate treatment. Relevant disclosures can be...

25 Feb 202522min

S3 Episode 1: Screening and Management of Metabolic Dysfunction-Associated Fatty Liver Disease in Endocrine Practice

S3 Episode 1: Screening and Management of Metabolic Dysfunction-Associated Fatty Liver Disease in Endocrine Practice

Drs Carol H. Wysham and Scott Isaacs discuss incorporating the screening and management of metabolic dysfunction–associated steatotic liver disease in endocrine practice. Relevant disclosures can be f...

25 Feb 202521min

S2 Episode 6: What's Next? Emerging Trends in Type 2 Diabetes Management

S2 Episode 6: What's Next? Emerging Trends in Type 2 Diabetes Management

Join Drs Carol Wysham and Silvio Inzucchi as they discuss how type 2 diabetes management has evolved over the years, and the most promising developments on the horizon. Relevant disclosures can be fou...

1 Jun 202324min

S2 Episode 5: Weight Management as a Goal in Type 2 Diabetes Care

S2 Episode 5: Weight Management as a Goal in Type 2 Diabetes Care

Join Drs Carol Wysham and Carel le Roux for practical, actionable strategies when targeting weight management as a key goal in type 2 diabetes prevention and treatment. Relevant disclosures can be fou...

3 Mai 202320min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
liberal-halvtime
forskningno
rekommandert
sinnsyn
rss-paradigmepodden
tomprat-med-gunnar-tjomlid
villmarksliv
rss-overskuddsliv
fjellsportpodden
kvinnehelsepodden
rss-nysgjerrige-norge
tidlose-historier
nevropodden
rss-inn-til-kjernen-med-sunniva-rose
dekodet-2
nordnorsk-historie
rss-rekommandert